138801-91-9Relevant academic research and scientific papers
Compounds advantageous in the treatment of central nervous system diseases and disorders
-
Page/Page column 18, (2015/12/25)
A series of novel compounds showing anticonvulsant activity is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system (“CNS”) diseases and disorders, such as anxiety, depression, insomnia,
Conformational and Steric Modifications of the Pyran Ring of the Potassium-Channel Activator Cromakalim
Buckle, Derek R.,Eggleston, Drake S.,Houge-Frydrych, Catherina S. V.,Pinto, Ivan L.,Readshaw, Simon A.,et al.
, p. 2763 - 2772 (2007/10/02)
The syntheses of analogues of the novel smooth muscle relaxant cromakalim, in which the C-2 methyl groups have been successively replaced by hydrogen, are described and the relative stereochemistry of the two corresponding, isomeric monomethyl compounds,
